Hi Dr T,
Congratulations on your appointment to CEO, good to see you back in the driver’s seat.
Are you referring to the ability of VO2Peak (compared to LVEF - left ventricle ejection fraction) to more accurately measure the negative effect of cardiotoxicity and therefore prove/quantify the cardio protect benefit of bisantrene? Or is there some other advantage that I am missing?
If it's just a better measure of heart health, why is this a bigger advantage than opening up the trial to many more cancer indications which I would have thought would increase significantly the TAM?
I didn’t see today’s presentation, waiting for the recorded video to be released.
- Forums
- ASX - By Stock
- RAC
- Ann: Bonus Options Prospectus
Ann: Bonus Options Prospectus, page-103
-
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.44 |
Change
0.040(2.86%) |
Mkt cap ! $245.3M |
Open | High | Low | Value | Volume |
$1.45 | $1.49 | $1.41 | $101.7K | 69.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9216 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 7767 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9216 | 1.440 |
1 | 1314 | 1.435 |
1 | 10000 | 1.420 |
1 | 4000 | 1.410 |
1 | 711 | 1.405 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 7767 | 2 |
1.480 | 3000 | 1 |
1.510 | 687 | 1 |
1.545 | 2040 | 1 |
1.550 | 5000 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |